Keyphrases
Glioblastoma
100%
Oncogene
100%
Multiple Signaling Pathways
100%
MicroRNA-575
100%
Cell Proliferation
18%
Overall Survival
18%
Tumorigenesis
18%
Functional Studies
18%
In Silico
18%
Overexpression
9%
Multivariable
9%
Tumor Samples
9%
Quantitative PCR
9%
Clinical Data
9%
MicroRNA
9%
Prognostic Value
9%
Kaplan-Meier
9%
Immunoblotting
9%
High-level Expression
9%
Cox Regression Analysis
9%
Cell Migration
9%
Colony Formation
9%
Survival Outcomes
9%
Clinical Variables
9%
Poor Survival
9%
Univariable Analysis
9%
Prognostic Biomarker
9%
Network Studies
9%
Patient Prognosis
9%
Mechanistic Studies
9%
Novel Biomarkers
9%
ERK Pathway
9%
Glioblastoma multiforme
9%
Total RNA
9%
Gene Network
9%
Multivariable Cox Regression
9%
In Vitro Growth
9%
Putative Targets
9%
Glioblastoma Cells
9%
Luciferase Reporter Assay
9%
Tumor Growth in Vivo
9%
Migration Assay
9%
Gene Network Analysis
9%
Primary Glioblastoma
9%
Overall Survival of Patients
9%
AKT Pathway
9%
CDKN1B
9%
Survival Period
9%
Tumorigenesis Mechanism
9%
NanoString Technology
9%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Carcinogenesis
100%
MicroRNA
100%
Oncogene
100%
Cell Proliferation
66%
Gene Network
66%
Real-Time Polymerase Chain Reaction
33%
Tumor Progression
33%
Luciferase
33%
RNA
33%
Cell Migration
33%
Colony Formation
33%
Survival Time
33%
CDKN1B
33%
Immunoblotting
33%
Neuroscience
Oncogene
100%
Carcinogenesis
100%
MicroRNA
100%
In Vivo
66%
In Vitro
66%
Cell Proliferation
66%
Real-Time Polymerase Chain Reaction
33%
Face
33%
Cell Migration
33%
Luciferase
33%
Colony Formation
33%
Cyclin Dependent Kinase Inhibitor 1B
33%
Immunoblotting
33%
Medicine and Dentistry
microRNA
100%
Glioblastoma
100%
Oncogene
100%
Cell Signaling Pathway
100%
Overall Survival
21%
Carcinogenesis
21%
In Vitro
14%
Cell Proliferation
14%
In Silico
14%
Biological Marker
7%
Neoplasm
7%
Real-Time Polymerase Chain Reaction
7%
Proportional Hazards Model
7%
Immunoblotting
7%
Tumor Progression
7%
Cell Migration
7%
Colony Formation
7%
Survival Time
7%
Luciferase Assay
7%
CDKN1B
7%
Immunology and Microbiology
Overall Survival
100%
Oncogene
100%
Cell Proliferation
66%
Real-Time Polymerase Chain Reaction
33%
Cell Migration
33%
Western Blot
33%
Face
33%
Colony Formation
33%
Survival Time
33%
Prognostic Biomarker
33%
Pharmacology, Toxicology and Pharmaceutical Science
Glioblastoma
100%
microRNA
100%
Overall Survival
21%
Carcinogenesis
21%
Neoplasm
7%
Tumor Growth
7%
Biological Marker
7%
Western Blot
7%
Luciferase
7%
Survival Time
7%
Cyclin Dependent Kinase Inhibitor 1B
7%